Content about Diabetes mellitus

March 25, 2013

The percentage of people who are at risk of developing Type 2 diabetes and aware of it has risen slightly over the past few years, but remains low, according to a report by the Centers for Disease Control and Prevention.

ATLANTA — The percentage of people who are at risk of developing Type 2 diabetes and aware of it has risen slightly over the past few years, but remains low, according to a report by the Centers for Disease Control and Prevention.

March 22, 2013

A drug made by Novo Nordisk for Type 2 diabetes produced a 6% loss of weight in a trial of the drug in obese patients, the company said.

BAGSVÆRD, Denmark — A drug made by Novo Nordisk for Type 2 diabetes produced a 6% loss of weight in a trial of the drug in obese patients, the company said.

The Danish drug maker announced results of a 56-week phase-3 trial to investigate the potential of Victoza (liraglutide) to produce and maintain weight loss in overweight and obese patients with Type 2 diabetes.

March 8, 2013

Drug maker Merck has hired celebrity chef and cookbook author Leticia Moreinos Schwartz as a spokeswoman to reach out to Hispanics living with Type 2 diabetes, the drug maker said.

WHITEHOUSE STATION, N.J. — Drug maker Merck has hired celebrity chef and cookbook author Leticia Moreinos Schwartz as a spokeswoman to reach out to Hispanics living with Type 2 diabetes, the drug maker said Friday.

March 7, 2013

The cost of diabetes has increased by more than $70 billion over the past five years, according to new research from the American Diabetes Association.

ALEXANDRIA, Va. — The cost of diabetes has increased by more than $70 billion over the past five years, according to new research from the American Diabetes Association.

The ADA announced the release of a report estimating that the total costs of diagnosed diabetes had risen 41%, from 2007's $174 billion to $245 billion in 2012. The report, Economic Costs of Diabetes in the U.S. in 2012, was commissioned by the ADA and addresses increased financial burden, health resources used and lost productivity associated with the disease.

February 22, 2013

The YMCA is offering a demonstration project to show that its YMCA Diabetes Prevention Program — part of the Centers for Disease Control and Prevention's broader National Diabetes Prevention Program — can lower the incidence of Type 2 diabetes and reduce medical costs incurred by Medicare. The Centers for Medicare and Medicaid Innovation is funding the project, whereby YMCAs in 17 communities that deliver the program will offer it at no cost to 10,000 Medicare enrollees over the next three years, and the YMCA expects it to save Medicare $4.2 million over three years and $53 million over six years.

It's been said that, "It takes a village to raise a child," and because chronic disease is an issue that affects communities as a whole - not just individuals - it would make sense for community-based organizations to target a growing national health crisis like the diabetes epidemic.

The YMCA is offering a demonstration project to show that its YMCA Diabetes Prevention Program — part of the Centers for Disease Control and Prevention's broader National Diabetes Prevention Program — can lower the incidence of Type 2 diabetes and reduce medical costs incurred by Medicare.

February 19, 2013

The YMCA is sponsoring a diabetes-control program that some say could slow the disease's spread, according to published reports.

NEW YORK — The YMCA is sponsoring a diabetes-control program that some say could slow the disease's spread, according to published reports.

February 19, 2013

Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.

NEW YORK — Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.

February 8, 2013

While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

PHILADELPHIA — While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

February 1, 2013

Face-to-face medication therapy management services can improve health outcomes for patients with diabetes, according to a new study.

ARLINGTON, Va. — Face-to-face medication therapy management services can improve health outcomes for patients with diabetes, according to a new study.

January 31, 2013

A nutritional supplement may help ward off gestational diabetes in pregnant women, according to a new study.

NEW YORK — A nutritional supplement may help ward off gestational diabetes in pregnant women, according to a new study.

The study, conducted by researchers at Italy's University of Messina and published in the journal Diabetes Care, found that pregnant women with family histories of Type 2 diabetes who received myo-inositol saw a significant reduction in the incidence of gestational diabetes, a condition that causes high blood sugar in some pregnant women.

January 28, 2013

The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said Friday.

The FDA announced the approval of Nesina (alogliptin), Kazano (alogliptin and metformin) and Oseni (alogliptin and pioglitazone) tablets.

Alogliptin is a new active ingredient, while metformin and pioglitazone are drugs already on the market.

January 28, 2013

In August 2012, the American Association of Diabetes Educators highlighted recommendations and research confirming that more than one-third of the 25 million Americans with diabetes don’t take their insulin as prescribed. Collaborative Care recently had the opportunity to interview Jerry Meece, a pharmacist, certified diabetes educator and author of the AADE’s recommendations, about what pharmacists are — and should be — doing to address the problem.

In August 2012, the American Association of Diabetes Educators highlighted recommendations and research confirming that more than one-third of the 25 million Americans with diabetes don’t take their insulin as prescribed, with 20% intentionally skipping doses and many admitting they inject it in the wrong place or at the wrong time or use the wrong technique, and only 30% of patients receive formal insulin education.

January 22, 2013

During its annual business review Tuesday, Johnson & Johnson announced that the recent introduction of the OneTouch Verio Glucose testing platform represented one of the first diabetes care devices to alert and display high/low patterns that deliver more meaningful and actionable insights to help patients better understand and manage their diabetes.

NEW YORK — During its annual business review Tuesday, Johnson & Johnson announced that the recent introduction of the OneTouch Verio Glucose testing platform represented one of the first diabetes care devices to alert and display high/low patterns that deliver more meaningful and actionable insights to help patients better understand and manage their diabetes.

January 11, 2013

A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

RARITAN, N.J. -- A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

J&J said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had recommended approval for canagliflozin, which the company plans to market under the name brand Invokana. The FDA is not required to follow the votes of advisory committees when deciding whether or not to approve a drug, but usually does.

January 2, 2013

While the "fiscal cliff" bill heads off the most severe tax implications for most Americans, the 25.8 million Americans with diabetes may find this bill a bitter pill to swallow, suggested the National Community Pharmacists Association in a press release.

ALEXANDRIA, Va. — While the "fiscal cliff" bill heads off the most severe tax implications for most Americans, the 25.8 million Americans with diabetes may find this bill a bitter pill to swallow, suggested the National Community Pharmacists Association in a press release issued Wednesday. 

December 14, 2012

Diabetes patients at Kroger pharmacies who have private insurance can pay $4 for blood-glucose test strips, the supermarket operator said.

CINCINNATI — Diabetes patients at Kroger pharmacies who have private insurance can pay $4 for blood-glucose test strips, the supermarket operator said.

Kroger said insured patients could pay a $4 co-pay for Kroger Premium test strips. People with diabetes can spend as much as $1,000 per year out of pocket on test strips alone, Kroger said.

December 12, 2012

A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

RARITAN, N.J. — A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

J&J division Janssen Research & Development announced Wednesday that it had filed with the Food and Drug Administration for a drug combining the experimental drug canagliflozin and immediate-release metformin, a common generic drug for diabetes.

The company also submitted a regulatory approval application to the FDA for canagliflozin in May 2012.

December 3, 2012

Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

NEW YORK — Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

The study, published in the journal Cancer, enrolled 61 patients who took metformin and 178 who didn't. Of those who took the drug, 67% were surviving after five years, compared with 47% of those who didn't take it. Further analysis indicated that patients taking metformin were almost four times likelier to survive than those not taking it.

December 3, 2012

Personal care company Naterra has announced the national launch of Phase+, a skin care line designed to address the cosmetic effects that diabetes has on the skin.

DALLAS — Personal care company Naterra has announced the national launch of Phase+, a skin care line designed to address the cosmetic effects that diabetes has on the skin. 

Phase+, which is now available at all Walgreens stores, is infused with anti-microbial ingredients to help prevent such skin care problems as cracked heels and ultra-dry skin from becoming a larger problem for diabetics, the company stated.    

November 29, 2012

Use of electronic health records 
improves medical outcomes among patients with diabetes, according to a recent study conducted by Kaiser Permanente.


Use of electronic health records 
improves medical outcomes among patients with diabetes, according to a recent study conducted by Kaiser Permanente.


November 16, 2012

People with diabetes in Cleveland enrolled in UnitedHealthcare employer-sponsored health plans can obtain free diabetes management services from Rite Aid, the retail pharmacy chain said Friday.

CLEVELAND — People with diabetes in Cleveland enrolled in UnitedHealthcare employer-sponsored health plans can obtain free diabetes management services from Rite Aid, the retail pharmacy chain said Friday.

The chain's pharmacists are participating in the Diabetes Control Program, part of UnitedHealth Group's Diabetes Prevention and Control Alliance, which is aimed at addressing the problem of Type 2 diabetes and prediabetes.

November 16, 2012

Walgreens and Take Care Clinics on Friday announced the offer of free health testing for hemoglobin A1C and blood glucose at more than 3,000 U.S. locations through the end of November as part of American Diabetes Month and the Walgreens Way to Well Commitment.

DEERFIELD, Ill. — Walgreens and Take Care Clinics on Friday announced the offer of free health testing for hemoglobin A1C and blood glucose at more than 3,000 U.S. locations through the end of November as part of American Diabetes Month and the Walgreens Way to Well Commitment. 

November 15, 2012

As more Americans join the ranks of diabetics, the opportunity to target these consumers at the shelf becomes more crucial. 


As more Americans join the ranks of diabetics, the opportunity to target these consumers at the shelf becomes more crucial. 


Retailers like Rite Aid are using pull-box displays that allow customers to physically handle a blood-glucose meter before they make that purchase decision. That kind of consumer engagement, evident throughout Rite Aid’s latest Wellness format store, for example, helps anchor diabetes as a front-end destination center. 


November 14, 2012

People with diabetes often develop clogged arteries that cause heart disease, and new research at Washington University School of Medicine in St. Louis suggests that low vitamin D levels are to blame.

ST. LOUIS — People with diabetes often develop clogged arteries that cause heart disease, and new research at Washington University School of Medicine in St. Louis suggests that low vitamin D levels are to blame. In a study published Nov. 9 in the Journal of Biological Chemistry, the researchers reported that blood vessels are less like to clog in people with diabetes who get adequate vitamin D. But in patients with insufficient vitamin D, immune cells bind to blood vessels near the heart, then trap cholesterol to block those blood vessels.

November 12, 2012

Cardinal Health on Monday announced the availability of free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing and living with diabetes as part of National Diabetes Awareness Month.

DUBLIN, Ohio — Cardinal Health on Monday announced the availability of free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing and living with diabetes as part of National Diabetes Awareness Month.